DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Which IPOs are open now in India?

The current list of open, upcoming and recently listed mainboard and SME IPOs — with price band, lot size, subscription dates and listing details — is on the DocStoX IPO calendar at https://docstox.com/ipos.

What is an IPO price band and lot size?

The price band is the range within which you can bid for IPO shares; the lot size is the minimum number of shares per application. You apply in multiples of the lot size within the band. DocStoX lists both for every open IPO.

What is the difference between a mainboard and an SME IPO?

Mainboard IPOs are larger companies listed on the main NSE/BSE boards with lower lot sizes and broad retail access; SME IPOs are smaller companies on the SME platforms with larger minimum investment and higher risk.

Mankind Pharma Limited IPO

ListedMainboard

Price band

₹1,026 – ₹1,080

Open – close

25 Apr 2023

to 27 Apr 2023

Listing

09 May 2023

Verdict Dates The offering Outcomes

What the filing actually says

Our read of the offer document and the exchange data — not the issuer's summary of itself

We can't judge this issue yet. A verdict needs at least three independent dimensions — valuation, growth, profitability, balance sheet, issue structure, governance or demand — and this issue does not yet publish enough of them for a read that would mean anything. No offer document for this issue has been published yet. A confident score from two fields would be worse than this notice.

Dates

The issuer's tentative timetable — a date passing is not confirmation the step completed

Opens
25 Apr 2023
Closes
27 Apr 2023
Listing
09 May 2023

The offering

Terms, structure and who is selling

Terms

Price band₹1,026 – ₹1,080

Listing atMainboard

Company & valuation

ISININE634S01028

What happened to comparable issues

The last 8 issues to list with a recorded opening price, most comparable first

Median listing gain

+6.7%

Listed up

6 of 8

Best

+47.2%

SS Retail Limited

Worst

-2.4%

Hero Motors Limited

NSEsame segment

5.7× sub+0.8%

Sonaselection India Limitedsame segment

2.0× sub+3.3%

Jindal Supreme (India) Limitedsame segment

177.0× sub+29.0%

SS Retail Limitedsame segment

107.4× sub+47.2%

Hero Motors Limitedsame segment

7.0× sub-2.4%

Manika Plastech Limitedsame segment

29.5× sub+0.0%

Veegaland Developers Limitedsame segment

14.6× sub+10.0%

Karamtara Engineering Limitedsame segment

66.0× sub+26.0%

Past issues are context, not a forecast — this issue is a different company at a different price. We show it because "how have issues like this one actually opened" is a question with a real answer, and grey-market premium is not that answer.

All IPOs MANKIND stock page

Disclaimer. Figures are compiled from the issuer's offer document and exchange-published bidding data. Subscription changes until the issue closes, and the final basis of allotment is published by the registrar. Grey-market premium is unofficial and is not a forecast. Nothing here is investment advice or a recommendation — read the offer document and consult a SEBI-registered adviser before applying.